Onivyde Post-Launch Patient Website Feb 20, 2018Feb 21, 2018 Brand: Onivyde (irinotecan liposome), Injection Parent Company: Ipsen Drug Type: Boxed Warning Drug Category: Oncology Campaign: Post-Launch Targeting: Patients, Caregivers Patient Website: HCP Website: https://www.onivyde.com/ Homepage Homepage Scrolled Homepage (Mobile)